The ATS 2017 COPD congress report brings you the latest developments in COPD as presented at the American Thoracic Society (ATS) congress, that took place from 19-24 May 2017 in Washington DC, USA.
The report covers pathophysiology, diagnosis and assessment of disease, pharmacological and non-pharmacological treatment, co-morbidities and exacerbations, to public health concerns, smoking cessation & eCigarettes, pulmonary rehabilitation, and use of digital technology. COPD experts, Dr Richard Russell, Dr Frits Franssen & Prof Michael Dreher provide insights on the clinical relevance and possible impact these developments will have on clinical practice.
Using this link will let you leave a website of Boehringer Ingelheim International GmbH (“BI”) or to a different domain under the control of BI. In the event that the linked site is not under the control of BI but under the control of a third party or an affiliate in the Boehringer Ingelheim group of companies, BI shall not be responsible for the contents, processing of personal data of any linked site or any link contained in a linked site, or any changes or updates to such sites. This link is provided to you only as a convenience, and the inclusion of any link does not imply endorsement by BI of the site.